| Alpha-synuclein as a biomarker of Parkinson’s disease: good, but not good enough U Ganguly, S Singh, S Pal, S Prasad, BK Agrawal, RV Saini, ... Frontiers in aging neuroscience 13, 702639, 2021 | 112 | 2021 |
| Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers S Kashyap, S Pal, G Chandan, V Saini, S Chakrabarti, NK Saini, A Mittal, ... Seminars in Cancer Biology 86, 643-651, 2022 | 34 | 2022 |
| Protective effects of cyclosporine A on neurodegeneration and motor impairment in rotenone-induced experimental models of Parkinson's disease S Singh, U Ganguly, S Pal, G Chandan, R Thakur, RV Saini, ... European Journal of Pharmacology 929, 175129, 2022 | 14 | 2022 |
| GLUT inhibitor WZB117 induces cytotoxicity with increased production of amyloid-beta peptide in SH-SY5Y cells preventable by beta-hydroxybutyrate: implications in Alzheimer’s … G Chandan, U Ganguly, S Pal, S Singh, RV Saini, SS Chakrabarti, ... Pharmacological Reports 75 (2), 482-489, 2023 | 4 | 2023 |
| Synthesis, characterization and anticancer activities of silver nanoparticles from the leaves of Datura stramonium L. G Chandan, S Pal, S Kashyap, SS Siwal, SK Dhiman, AK Saini, RV Saini Nanofabrication 6 (1), 25-35, 2021 | 4 | 2021 |
| The colloquy between microbiota and the immune system in colon cancer: repercussions on the cancer therapy S Pal, AK Saini, A Kaushal, S Gupta, NA Gaur, AK Chhillar, AK Sharma, ... Current Pharmaceutical Design 28 (43), 3478-3485, 2022 | 2 | 2022 |
| Green Synthesized Nanoparticles for Sustainable Agriculture D Mittal, RV Saini, R Thakur, S Pal, J Das, SS Siwal, AK Saini Microbes in Agri-Forestry Biotechnology, 305-318, 2022 | | 2022 |